$ETTX Entasis Therapeutics Holdings Inc. Insider Trading
Get free email notifications about insider trading in Entasis Therapeutics Holdings Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Entasis Therapeutics Holdings Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Entasis Therapeutics Holdings Inc. for free.
CIK Number: 0001724344
IRS Number: 824592913
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ETTX
Company Address: 35 GATEHOUSE DRIVE WALTHAM 02451
Phone number: 781-810-0120
Former name: Entasis Therapeutics Ltd, date of change: 2017-12-04
Entasis Therapeutics Holdings Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 02 2021 | ETTX | Entasis Therapeuti ... | Mayer Howard | Director | Grant | A | 0.00 | 22,000 | 0 | 22,000 | 0 to 22 K |
Apr 02 2021 | ETTX | Entasis Therapeuti ... | Behanna Heather | Director | Grant | A | 0.00 | 22,000 | 0 | 22,000 | 0 to 22 K |
Apr 02 2021 | ETTX | Entasis Therapeuti ... | Meek David D. | Director | Grant | A | 0.00 | 22,000 | 0 | 22,000 | 0 to 22 K |
Apr 02 2021 | ETTX | Entasis Therapeuti ... | HASTINGS DAVID C | Director | Grant | A | 0.00 | 22,000 | 0 | 22,000 | 0 to 22 K |
Jan 19 2021 | ETTX | Entasis Therapeuti ... | Tommasi Ruben | Chief Scientific Of ... | Grant | A | 0.00 | 25,000 | 0 | 47,024 | 22 K to 47 K (+113.51 %) |
Jan 19 2021 | ETTX | Entasis Therapeuti ... | Ronsheim Matthew | See Remarks | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Jan 19 2021 | ETTX | Entasis Therapeuti ... | Perros Manoussos | President & CEO | Grant | A | 0.00 | 79,750 | 0 | 79,750 | 0 to 79.8 K |
Jan 19 2021 | ETTX | Entasis Therapeuti ... | Keiley Elizabeth M | General Counsel | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Jan 19 2021 | ETTX | Entasis Therapeuti ... | Altarac David | Chief Medical Offic ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Jan 19 2021 | ETTX | Entasis Therapeuti ... | Mueller John Patrick | Chief Development O ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Oct 06 2020 | ETTX | Entasis Therapeuti ... | Meek David D. | Director | Option Exercise | A | 2.98 | 11,000 | 32,780 | 11,000 | |
Oct 06 2020 | ETTX | Entasis Therapeuti ... | HASTINGS DAVID C | Director | Option Exercise | A | 2.98 | 11,000 | 32,780 | 11,000 | |
Oct 06 2020 | ETTX | Entasis Therapeuti ... | Behanna Heather | Director | Option Exercise | A | 2.98 | 11,000 | 32,780 | 11,000 | |
Oct 06 2020 | ETTX | Entasis Therapeuti ... | Mayer Howard | Director | Option Exercise | A | 2.98 | 11,000 | 32,780 | 11,000 | |
Sep 01 2020 | ETTX | Entasis Therapeuti ... | Innoviva, Inc. | 10% Owner | Option Exercise | P | 2.68 | 4,672,897 | 12,499,999 | 18,672,897 |
View all Entasis Therapeutics Holdings Inc. insider transactions.